1. Home
  2. PRI vs RGEN Comparison

PRI vs RGEN Comparison

Compare PRI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primerica Inc.

PRI

Primerica Inc.

HOLD

Current Price

$260.23

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$172.35

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRI
RGEN
Founded
1927
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRI
RGEN
Price
$260.23
$172.35
Analyst Decision
Hold
Buy
Analyst Count
4
10
Target Price
$304.25
$174.90
AVG Volume (30 Days)
238.1K
550.6K
Earning Date
02-10-2026
02-19-2026
Dividend Yield
1.58%
N/A
EPS Growth
65.97
N/A
EPS
21.75
0.03
Revenue
$3,335,204,000.00
$707,890,000.00
Revenue This Year
$4.64
$17.84
Revenue Next Year
$4.73
$12.44
P/E Ratio
$12.07
$6,658.81
Revenue Growth
10.41
11.74
52 Week Low
$230.98
$102.97
52 Week High
$298.75
$182.52

Technical Indicators

Market Signals
Indicator
PRI
RGEN
Relative Strength Index (RSI) 52.74 65.21
Support Level $256.06 $162.21
Resistance Level $267.50 $167.65
Average True Range (ATR) 4.55 4.82
MACD 0.27 0.47
Stochastic Oscillator 36.48 82.67

Price Performance

Historical Comparison
PRI
RGEN

About PRI Primerica Inc.

Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: